Your browser doesn't support javascript.
loading
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
Zeremski, Vanja; McPhail, Ellen D; Habermann, Thomas M; Schieppati, Francesca; Gebauer, Niklas; Vassilakopoulos, Theodoros P; Mougiakakos, Dimitrios.
Afiliación
  • Zeremski V; Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • McPhail ED; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Habermann TM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Schieppati F; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Gebauer N; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Luebeck, Germany.
  • Vassilakopoulos TP; Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
  • Mougiakakos D; Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Hematol Oncol ; 41(4): 776-780, 2023 10.
Article en En | MEDLINE | ID: mdl-36945194

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania